Bausch + Lomb issued the recall after the company received reports of toxic anterior segment syndrome, or an inflammatory ...

NEW YORK CITY, NY / ACCESS Newswire / April 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

THURSDAY, April 10, 2025 (HealthDay News) -- Bausch + Lomb has announced a voluntary recall of intraocular lenses on its ...

The eye health company Bausch + Lomb announced on Monday that it is recalling several of its intraocular lenses due to safety ...

Bausch Health's Aplenzin could revolutionize TRD care, addressing a $3B market opportunity while aiding BHC stock's financial ...

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst ...

Bausch Health, Canada & pCPA sign LoI for public drug plan coverage of PrCABTREO for treatment of acne vulgaris: Laval, Quebec Saturday, April 12, 2025, 10:00 Hrs [IST] Bausch Hea ...

Bausch + Lomb is recalling intraocular lenses (IOLs) on its enVista platform. This action was taken after the company ...

Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with application submissions open through June 11, 2025 LAVAL, QC / ACCESS Newswire / April 10, 2025 / ...

Learn more about whether Bausch + Lomb Corporation or Penumbra, Inc. is a better investment based on AAII's A+ Investor ...

Bausch + Lomb BLCO shares ended the last trading session 13.9% higher at $12.53. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

(RTTNews) - Eye health firm Bausch + Lomb Corp. has recalled certain intraocular lenses or IOLs on its enVista platform following reports of complications, the cause of which could not immediately ...